Literature DB >> 26045986

MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.

Hui Meng1, Kai Wang1, Xuedan Chen1, Xingying Guan1, Liwen Hu2, Gang Xiong2, Juan Li1, Yun Bai1.   

Abstract

MicroRNAs comprise a family of small non-coding RNA molecules that have emerged as key post-transcriptional regulators of gene expression. Aberrant miRNA expression has been linked to various human tumors. This study was aimed to identify novel miRNAs involved in the carcinogenesis of esophageal squamous cell carcinoma (ESCC) and their potential functions. We performed miRNA microarray and found that miR-330-3p was highly expressed in ESCC tumor tissues. qRT-PCR further confirmed the result in other 35 pairs of ESCC tumor tissues and ESCC cell lines. Ectopic expression of miR-330-3p significantly promoted ESCC cell proliferation, survival, migration, invasion in vitro and stimulated tumor formation in nude mice. Knockdown of miR-330-3p leaded to the opposite effects. The luciferase assay confirmed that miR-330-3p directly interacted with the PDCD4 mRNA 3' un-translated region (UTR). Moreover, expression of PDCD4 was inversely associated with miR-330-3p in ESCC tissues. Silencing of PDCD4 significantly promoted cell growth, cell migration, invasion and inhibited cisplatin-induced apoptosis in ESCC cells. This study suggested that miR-330-3p might play an oncogenic role in the development of ESCC partially via suppression of PDCD4 expression.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; PDCD4; cell invasion; cell proliferation; miR-330-3p

Year:  2015        PMID: 26045986      PMCID: PMC4449435     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  42 in total

1.  MiR-9 downregulates CDX2 expression in gastric cancer cells.

Authors:  Pichayanoot Rotkrua; Yoshimitsu Akiyama; Yutaka Hashimoto; Takeshi Otsubo; Yasuhito Yuasa
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

2.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Authors:  Aaron P Jansen; Corinne E Camalier; Nancy H Colburn
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

4.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

5.  Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.

Authors:  Patricia P Reis; Miranda Tomenson; Nilva K Cervigne; Jerry Machado; Igor Jurisica; Melania Pintilie; Mahadeo A Sukhai; Bayardo Perez-Ordonez; Reidar Grénman; Ralph W Gilbert; Patrick J Gullane; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Mol Cancer       Date:  2010-09-10       Impact factor: 27.401

6.  Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.

Authors:  Tobias Schmid; Aaron P Jansen; Alyson R Baker; Glenn Hegamyer; John P Hagan; Nancy H Colburn
Journal:  Cancer Res       Date:  2008-02-22       Impact factor: 12.701

7.  HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.

Authors:  X Qiu; S Dong; F Qiao; S Lu; Y Song; Y Lao; Y Li; T Zeng; J Hu; L Zhang; L Zhang; H Fan
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

8.  Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.

Authors:  Olubunmi Afonja; Dominique Juste; Sharmistha Das; Sachiko Matsuhashi; Herbert H Samuels
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

9.  Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.

Authors:  Aaron P Jansen; Corinne E Camalier; Cristi Stark; Nancy H Colburn
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

10.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  30 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

2.  MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.

Authors:  Xue-Zhi Wu; Kui-Peng Wang; Hong-Jie Song; Jian-Hua Xia; Yan Jiang; Yong-Lian Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.

Authors:  Xiao Hu; Yujie Feng; Lin Sun; Linlin Qu; Chuandong Sun
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

5.  The homeostatic malfunction of a novel feedback pathway formed by lncRNA021545, miR-330-3p and epiregulin contributes in hepatocarcinoma progression via mediating epithelial-mesenchymal transition.

Authors:  Siwen Yang; Yunkun Zhang; Chunmei Guo; Rui Liu; Maroua Elkharti; Zhenhua Ge; Qinlong Liu; Shuqing Liu; Ming-Zhong Sun
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

6.  MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.

Authors:  Shanghui Guan; Cong Wang; Xuan Chen; Bowen Liu; Bingxu Tan; Fang Liu; Ding Wang; Lihui Han; Lu Wang; Xiaochen Huang; Jiangfeng Wang; Bin Yao; Jialei Shi; Pengxiang Chen; Effat Un Nesa; Qingxu Song; Yufeng Cheng
Journal:  Tumour Biol       Date:  2015-10-24

7.  Identification of the Key Genes and Pathways in Esophageal Carcinoma.

Authors:  Peng Su; Shiwang Wen; Yuefeng Zhang; Yong Li; Yanzhao Xu; Yonggang Zhu; Huilai Lv; Fan Zhang; Mingbo Wang; Ziqiang Tian
Journal:  Gastroenterol Res Pract       Date:  2016-10-12       Impact factor: 2.260

8.  The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.

Authors:  Jiahui Liu; Libo Liu; Shuo Chao; Yunhui Liu; Xiaobai Liu; Jian Zheng; Jiajia Chen; Wei Gong; Hao Teng; Zhen Li; Ping Wang; Yixue Xue
Journal:  Front Cell Neurosci       Date:  2017-12-19       Impact factor: 5.505

9.  Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway.

Authors:  Changwei Dou; Zhenyu Zhou; Qiuran Xu; Zhikui Liu; Yuqun Zeng; Yufeng Wang; Qing Li; Liang Wang; Wei Yang; Qingguang Liu; Kangsheng Tu
Journal:  Oncogene       Date:  2018-09-24       Impact factor: 8.756

10.  Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.

Authors:  Yuanyuan Wu; Liwen Hu; Yan Liang; Juan Li; Kai Wang; Xuedan Chen; Hui Meng; Xingying Guan; Kang Yang; Yun Bai
Journal:  Mol Cancer       Date:  2017-08-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.